gougerotin

gougerotin Structure
CAS No.
2096-42-6
Chemical Name:
gougerotin
Synonyms
Z6572500;gougerotin;Asteromycin;Aspiculamycin;β-D-Glucopyranuronamide, 1-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,4-dideoxy-4-[(N-methylglycyl-D-seryl)amino]-;1-(2-Oxo-4-amino-1,2-dihydropyrimidine-1-yl)-4-(N-methyl-Gly-D-Ser-amino)-1,4-dideoxy-β-D-glucopyranulonamide;6-(4-amino-2-keto-pyrimidin-1-yl)-4,5-dihydroxy-3-[[3-hydroxy-2-(sarcosylamino)propanoyl]amino]tetrahydropyran-2-carboxamide;6-(4-amino-2-oxopyrimidin-1-yl)-4,5-dihydroxy-3-[[3-hydroxy-2-[[2-(methylamino)acetyl]amino]propanoyl]amino]oxane-2-carboxamide;6-(4-azanyl-2-oxo-pyrimidin-1-yl)-4,5-dihydroxy-3-[[3-hydroxy-2-[2-(methylamino)ethanoylamino]propanoyl]amino]oxane-2-carboxamide;1-(4-Amino-1,2-dihydro-2-oxopyrimidin-1-yl)-1,4-dideoxy-4-[[(R)-3-hydroxy-2-[[(methylamino)acetyl]amino]-1-oxopropyl]amino]-β-D-glucopyranulonamide
CBNumber:
CB81376667
Molecular Formula:
C16H25N7O8
Molecular Weight:
443.41
MOL File:
2096-42-6.mol
Modify Date:
2023/4/23 13:52:06

gougerotin Properties

Melting point 211-217° (dec)
alpha D27 +53° (c = 0.8)
Boiling point 553.74°C (rough estimate)
Density 1.2429 (rough estimate)
refractive index 1.6800 (estimate)
color Needles from MeOH

SAFETY

Risk and Safety Statements

Toxicity LD50 in mice (mg/kg): 57 i.v. (Kanzaki)

gougerotin Chemical Properties,Uses,Production

Safety Profile

Poison by intraperitoneal andintravenous routes. When heated to decomposition itemits toxic fumes of NOx.

gougerotin Preparation Products And Raw materials

Raw materials

Preparation Products

gougerotin Suppliers

Global( 5)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
BOC Sciences 16314854226; +16314854226 United States 19743 58 Inquiry
Shaanxi Xihua Chemical Industry Co., Ltd 17691182729 13992773979 China 7220 58 Inquiry
TargetMol Chemicals Inc. 15002134094 China 19696 58 Inquiry
Zhejiang Huida Biotech Co., LTD 0571-0571-89903882 15990081639 China 3705 58 Inquiry
Zhejiang Huida Biotech Co., LTD 0571-89903882 13626641628 China 3656 58 Inquiry
gougerotin 1-(2-Oxo-4-amino-1,2-dihydropyrimidine-1-yl)-4-(N-methyl-Gly-D-Ser-amino)-1,4-dideoxy-β-D-glucopyranulonamide 1-(4-Amino-1,2-dihydro-2-oxopyrimidin-1-yl)-1,4-dideoxy-4-[[(R)-3-hydroxy-2-[[(methylamino)acetyl]amino]-1-oxopropyl]amino]-β-D-glucopyranulonamide Aspiculamycin Asteromycin Z6572500 6-(4-amino-2-keto-pyrimidin-1-yl)-4,5-dihydroxy-3-[[3-hydroxy-2-(sarcosylamino)propanoyl]amino]tetrahydropyran-2-carboxamide 6-(4-amino-2-oxopyrimidin-1-yl)-4,5-dihydroxy-3-[[3-hydroxy-2-[[2-(methylamino)acetyl]amino]propanoyl]amino]oxane-2-carboxamide 6-(4-azanyl-2-oxo-pyrimidin-1-yl)-4,5-dihydroxy-3-[[3-hydroxy-2-[2-(methylamino)ethanoylamino]propanoyl]amino]oxane-2-carboxamide β-D-Glucopyranuronamide, 1-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,4-dideoxy-4-[(N-methylglycyl-D-seryl)amino]- 2096-42-6 C16H25N7O8